Literature DB >> 14315110

IMMUNOLOGICAL RESPONSES OF THE MAMMALIAN HOST AGAINST TAPEWORM INFECTIONS. 3. SPECIES SPECIFICITY OF HEXACANTH EMBRYOS IN PROTECTING SHEEP AGAINST TAENIA OVIS.

M A GEMMELL.   

Abstract

Entities:  

Keywords:  ANTIGENS; CESTODE INFECTIONS; EXPERIMENTAL LAB STUDY; IMMUNIZATION; OVUM; SHEEP; TAENIA; VACCINES

Mesh：

Substances：

Year:  1965        PMID： 14315110      PMCID： PMC1423459     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  6 in total

1.  The immunological response of the rat to infection with Taenia taeniaeformis. VII. Immunization by oral and parenteral administration of antigens.

Authors:  J M Ayuya; J F Williams
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

2.  Immunisation of mice against Taenia taeniaeformis using antigens prepared from T. pisiformis and T. hydatigena eggs or oncospheres.

Authors:  M D Rickard; G R Rajasekariah; G F Mitchell
Journal:  Z Parasitenkd       Date:  1981

Review 3.  Heterologous antagonistic and synergistic interactions between helminths and between helminths and protozoans in concurrent experimental infection of mammalian hosts.

Authors:  N O Christensen; P Nansen; B O Fagbemi; J Monrad
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

Review 4.  The development of acquired immunity to tapeworms and progress towards active immunization, with special reference to Echinococcus spp.

Authors:  M A Gemmell; E J Soulsby
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

Review 5.  The immunology of human and animal cysticercosis: a review.

Authors:  A Flisser; R Pérez-Montfort; C Larralde
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

6.  The Styx field-trial. A study on the application of control measures against hydatid disease caused by Echinococcus granulosus.

Authors:  M A Gemmell
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.